SRPT vs TTI · rev $1.90B vs P/E 170, $1.50B cap
Sarepta Therapeutics Inc (SRPT) versus Tetra Technologies Inc (TTI) — a side-by-side from cached financials, not a winner call.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Tetra Technologies Inc (TTI) is a conglomerates company listed on NYSE.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
TTI does not have a complete income-statement cache yet.
SRPT currently screens at market cap $2.34B. TTI currently screens at market cap $1.50B and trailing P/E 169.5.
Not investment advice. Open the SRPT and TTI stock pages for the full models.
Not investment advice.